Phase III study (20050181) of panitumumab (pmab) with FOLFIRI versus FOLFIRI alone as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC): Pooled safety results

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 26; no. 15_suppl; p. 4064
Main Authors Peeters, M., Wilson, G., Ducreux, M., Cervantes, A., André, T., Hotko, Y., Lordick, F., Collins, S., Shing, M., Price, T. J.
Format Journal Article
LanguageEnglish
Published 20.05.2008
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2008.26.15_suppl.4064